Celltrion
068270.KS
#786
Rank
S$34.36 B
Marketcap
$166.34
Share price
-0.12%
Change (1 day)
-6.83%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): $4.08

According to Celltrion 's latest financial reports the company's current EPS (TTM) is $4.02. In 2022 the company made an earnings per share (EPS) of $3.92 a decrease over its 2021 EPS that were of $4.66.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$4.084.2%
2022$3.92-15.84%
2021$4.6612.77%
2020$4.1370.79%
2019$2.4215.63%
2018$2.09-33.13%
2017$3.13141.17%
2016$1.308.28%
2015$1.2011.28%
2014$1.0816.37%
2013$0.92-67.42%
2012$2.8484.22%
2011$1.5462.13%
2010$0.9580.61%
2009$0.53-559.63%
2008-$0.11-123.16%
2007$0.49